| Preexposure chemoprophylaxis for HIV prevention in men who have sex with men RM Grant, JR Lama, PL Anderson, V McMahan, AY Liu, L Vargas, ... New England Journal of Medicine 363 (27), 2587-2599, 2010 | 5908 | 2010 |
| Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study RM Grant, PL Anderson, V McMahan, A Liu, KR Amico, M Mehrotra, ... The Lancet infectious diseases 14 (9), 820-829, 2014 | 1302 | 2014 |
| Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men PL Anderson, DV Glidden, A Liu, S Buchbinder, JR Lama, JV Guanira, ... Science translational medicine 4 (151), 151ra125-151ra125, 2012 | 1084 | 2012 |
| Use of a vaginal ring containing dapivirine for HIV-1 prevention in women JM Baeten, T Palanee-Phillips, ER Brown, K Schwartz, LE Soto-Torres, ... New England Journal of Medicine 375 (22), 2121-2132, 2016 | 864 | 2016 |
| Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals SD Lawn, LG Bekker, RF Miller The Lancet infectious diseases 5 (6), 361-373, 2005 | 758 | 2005 |
| Effectiveness of BNT162b2 vaccine against omicron variant in South Africa S Collie, J Champion, H Moultrie, LG Bekker, G Gray New England Journal of Medicine 386 (5), 494-496, 2022 | 695 | 2022 |
| Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay … MD Simek, W Rida, FH Priddy, P Pung, E Carrow, DS Laufer, JK Lehrman, ... Journal of virology 83 (14), 7337-7348, 2009 | 679 | 2009 |
| Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination E Nemes, H Geldenhuys, V Rozot, KT Rutkowski, F Ratangee, N Bilek, ... New England Journal of Medicine 379 (2), 138-149, 2018 | 645 | 2018 |
| Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism MJ Kim, HC Wainwright, M Locketz, LG Bekker, GB Walther, C Dittrich, ... EMBO molecular medicine 2 (7), 258-274, 2010 | 522 | 2010 |
| T cell responses to SARS-CoV-2 spike cross-recognize Omicron R Keeton, MB Tincho, A Ngomti, R Baguma, N Benede, A Suzuki, K Khan, ... Nature 603 (7901), 488-492, 2022 | 502 | 2022 |
| Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women A Nel, N van Niekerk, S Kapiga, LG Bekker, C Gama, K Gill, A Kamali, ... New England Journal of Medicine 375 (22), 2133-2143, 2016 | 477 | 2016 |
| Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control SD Lawn, L Myer, LG Bekker, R Wood Aids 20 (12), 1605-1612, 2006 | 477 | 2006 |
| Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design SD Lawn, L Myer, C Orrell, LG Bekker, R Wood Aids 19 (18), 2141-2148, 2005 | 467 | 2005 |
| Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis AE DeBarber, K Mdluli, M Bosman, LG Bekker, CE Barry 3rd Proceedings of the National Academy of Sciences 97 (17), 9677-9682, 2000 | 465 | 2000 |
| Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa SD Lawn, L Myer, LG Bekker, R Wood Aids 21 (3), 335-341, 2007 | 462 | 2007 |
| Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study GE Gray, M Allen, Z Moodie, G Churchyard, LG Bekker, M Nchabeleng, ... The Lancet infectious diseases 11 (7), 507-515, 2011 | 453 | 2011 |
| Mycobacterium tuberculosis Growth at theCavity Surface: a Microenvironment with FailedImmunity G Kaplan, FA Post, AL Moreira, H Wainwright, BN Kreiswirth, M Tanverdi, ... Infection and immunity 71 (12), 7099-7108, 2003 | 450 | 2003 |
| Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa SD Lawn, L Myer, D Edwards, LG Bekker, R Wood Aids 23 (13), 1717-1725, 2009 | 413 | 2009 |
| Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study SD Lawn, SV Brooks, K Kranzer, MP Nicol, A Whitelaw, M Vogt, ... PLoS medicine 8 (7), e1001067, 2011 | 404 | 2011 |
| Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages D Stucki, D Brites, L Jeljeli, M Coscolla, Q Liu, A Trauner, L Fenner, ... Nature genetics 48 (12), 1535-1543, 2016 | 371 | 2016 |
